Rare diseases
Investigational molecules
Locations
51 Sleeper Street, 02210-1276, United States
Odyssey Therapeutics Inc. is active in clinical research focused on ulcerative colitis, with attention to patients living with moderately to severely active disease. Its trial activity is centered on therapeutic options for intestinal inflammation and disease control.
The sponsor’s research interest includes treatment strategies aimed at improving gastrointestinal inflammation and clinical outcomes in colonic disease.
Odyssey Therapeutics Inc. runs clinical trials in conditions such as Colitis ulcerative, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
